PCIF1 and neoplasm: Instead, PCIF1 knockout appears to enhance anti‐PD1 efficacy by reducing tumour aggressiveness rather than altering the immune microenvironment, suggesting a novel mechanism for sensitizing tumours to immunotherapy.